Literature DB >> 3290264

Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.

D J Versluis1, F J Ten Kate, G J Wenting, J Jeekel, W Weimar.   

Abstract

To determine the type and reversibility of the long term effects of cyclosporin A, biopsy specimens were taken from 20 recipients of kidney allografts, twelve months after transplantation, and three months later, during which time azathioprine was substituted for cyclosporin A. Arteriolar IgM and complement deposits and tubular isometric vacuolisation associated with cyclosporin A treatment significantly regressed after stopping this drug one year after transplantation. Conversion to azathioprine was accompanied by an increase in mononuclear cell infiltrates and tubulitis despite an evident improvement in renal function. Nephrotoxicity as a result of cyclosporin A is common but can be reversed--at least partially.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290264      PMCID: PMC1141500          DOI: 10.1136/jcp.41.5.498

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  A high carbohydrate leguminous fibre diet improves all aspects of diabetic control.

Authors:  H C Simpson; R W Simpson; S Lousley; R D Carter; M Geekie; T D Hockaday; J I Mann
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

2.  Cyclosporine nephrotoxicity.

Authors:  W M Bennett; J P Pulliam
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

3.  Cyclosporin-induced nephrotoxicity. Inevitable and intractable?

Authors:  T B Strom; R Loertscher
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

4.  Characteristics of early routine renal allograft biopsies.

Authors:  J F Burdick; W E Beschorner; W J Smith; D McGraw; W L Bender; G M Williams; K Solez
Journal:  Transplantation       Date:  1984-12       Impact factor: 4.939

5.  Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies.

Authors:  R R Verani; S M Flechner; C T Van Buren; B D Kahan
Journal:  Am J Kidney Dis       Date:  1984-09       Impact factor: 8.860

6.  Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why.

Authors:  D J Versluis; G J Wenting; F H Derkx; M A Schalekamp; J Jeekel; W Weimar
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939

7.  Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period.

Authors:  G Klintmalm; S O Bohman; B Sundelin; H Wilczek
Journal:  Lancet       Date:  1984-10-27       Impact factor: 79.321

8.  Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin.

Authors:  A Farnsworth; B M Hall; A B Ng; G G Duggin; J S Horvath; A G Sheil; D J Tiller
Journal:  Am J Surg Pathol       Date:  1984-04       Impact factor: 6.394

9.  Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.

Authors:  R K Sibley; J Rynasiewicz; R M Ferguson; D Fryd; D E Sutherland; R L Simmons; J S Najarian
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

10.  Glomerular thrombi in renal allografts associated with cyclosporin treatment.

Authors:  G H Neild; R Reuben; R B Hartley; J S Cameron
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

View more
  2 in total

1.  Cyclosporine-induced nephrotoxicity in deoxycorticosterone-NaCl treated rats.

Authors:  J M Wyss; M S Mozaffari; P L St John; D R Abrahamson
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

2.  Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats.

Authors:  Elahe Sattarinezhad; Mohammad Reza Panjehshahin; Simin Torabinezhad; Eskandar Kamali-Sarvestani; Shirin Farjadian; Fatema Pirsalami; Leila Moezi
Journal:  Iran J Med Sci       Date:  2017-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.